Skip to main content
. 2022 Feb 17;12:2738. doi: 10.1038/s41598-022-06585-x

Table 2.

Cancer related variables summary table.

Characteristic No residual cancer, N = 2972 Residual cancer, N = 684 p-value1 OR 95% Cl
Size of grossly visible tumor 0.016
Less than 1 cm 315 (11%) 97 (14%) – –
1–2 cm 442 (15%) 87 (13%) 0.59 0.41, 0.85
Greeter than 2 cm 2215 (75%) 500 (73%) 0.65 0.49, 0.87
Gross abdominal disease-lymph nodes 0.12
No 2256 (76%) 499 (73%) – –
Yes 716 (24%) 185 (27%) 1.07 0.86, 1.34
Gross abdominal disease-bowel serosa  < 0.001
No 2207 (74%) 292 (43%) – –
Yes 765 (26%) 392 (57%) 1.67 1.36, 2.04
Gross abdominal disease-rowel mesentery  < 0.001
No 1651 (56%) 129 (19%) – –
Yes 1321 (44%) 555 (81%) 1.90 1.49, 2.43
Gross abdominal disease-live  < 0.001
No 2817 (95%) 562 (82%) – –
Yes 155 (5.2%) 122 (18%) 1.56 1.15, 2.10
Gross abdominal disease-spleen  < 0.001
No 2886 (97%) 619 (90%) – –
Yes 86 (12.9%) 65 (9.5%) 1.04 0.71, 1.52
Gross abdominal disease-diaphragm  < 0.001
No 2651 (89%) 360 (53%) – –
Yes 321 (11%) 324 (47%) 3.57 2.88, 4.44
Gross abdominal disease-pelvis  < 0.001
No 1410 (47%) 152 (22%) – –
Yes 1562 (53%) 532 (78%) 1.81 1.46, 2.26
Cervical cancer FIGO stage  < 0.001
0–1B2 164 (5.5%) 3 (0.4%) – –
II–IVB 100 (3.4%) 16 (2.3%) 3.07 0.91, 14.1
Not a cervical cancer case 2708 (91%) 665 (97%) 3.86 1.37, 16.2
Corpus uteri cancer stage  < 0.001
0–II 561 (19%) 19 (2.8%) – –
IIA–IIIC 580 (20%) 142 (21%) 3.88 2.33, 6.81
IV–IVB 29 (1.0%) 14 (2.0%) 6.19 2.60, 14.5
Not a corpus uteri cancer case 1802 (61%) 509 (74%) 2.93 1.74, 5.18
Ovarian cancer stage  < 0.001
I–III 560 (19%) 42 (6.1%) – –
IIIA–IV 1050 (35%) 457 (67%) 2.23 1.56, 3.24
Not an ovarian cancer case 1362 (46%) 185 (27%) 1.68 1.09, 2.62

OR odds ratio, CI confidence interval.

1Continvous Variable: one-way ANOVA, Binary Variable: Fisher’s Exact Test, Categorical Variable: Chi-Squared Test.